Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Reding

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2004
Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitorA A Ashrani, M T Reding, A Shet, et al.
BMJ Open|September 3, 2021
Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia AMartin Sanabria, María Teresa Álvarez Román, Giancarlo Castaman, et al.
Advances in Experimental Medicine and Biology|September 14, 2001
CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor productionM T Reding, H Wu, M Krampf, et al.
Thrombosis and Haemostasis|December 22, 1999
CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjectsM T Reding, H Wu, M Krampf, et al.
Thrombosis and Haemostasis|November 1, 2000
Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjectsM T Reding, H Wu, M Krampf, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2013
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)M J Manco-Johnson, C L Kempton, M T Reding, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2016
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIIIM T Reding, H J Ng, L H Poulsen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2017
Effect of late prophylaxis in hemophilia on joint status: a randomized trialM J Manco-Johnson, B Lundin, S Funk, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2004
Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitorA A Ashrani, M T Reding, A Shet, et al.
BMJ Open|September 3, 2021
Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia AMartin Sanabria, María Teresa Álvarez Román, Giancarlo Castaman, et al.
Advances in Experimental Medicine and Biology|September 14, 2001
CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor productionM T Reding, H Wu, M Krampf, et al.
Thrombosis and Haemostasis|December 22, 1999
CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjectsM T Reding, H Wu, M Krampf, et al.
Thrombosis and Haemostasis|November 1, 2000
Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjectsM T Reding, H Wu, M Krampf, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2013
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)M J Manco-Johnson, C L Kempton, M T Reding, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2016
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIIIM T Reding, H J Ng, L H Poulsen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2017
Effect of late prophylaxis in hemophilia on joint status: a randomized trialM J Manco-Johnson, B Lundin, S Funk, et al.
Pageof 2